Announcements Trials
Browse Landscape

Phase

Phase 2 61Phase 3 25Phase 1 20Phase 1/2 18Phase 2/3 6Phase NA 3

Status

Unknown 3Recruiting 3Completed 2Active not recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1

Conditions

Stomach Neoplasms 1Pancreatic Neoplasms 1Extensive Stage Small Cell Lung Cancer (ES-SCLC) 1

Interventions

Blood Specimen Collection 106Standard of Care 81Exercise 68Radiotherapy 54Radiosurgery 47Magnetic Resonance Spectroscopy 46Specimen Handling 45Surveys and Questionnaires 43Practice Guidelines as Topic 43Interviews as Topic 43Educational Status 42Methods 41Drug Therapy 34Early Intervention, Educational 30Surgical Procedures, Operative 29Palliative Care 25Biopsy 24Control Groups 21venetoclax 17Patient Navigation 17Cisplatin 17Therapeutics 16Proton Therapy 15Magnetic Resonance Imaging 15Behavior Therapy 15Neoadjuvant Therapy 14Cognitive Behavioral Therapy 13Acupuncture Therapy 13Resistance Training 12Nutritional Status 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Recruiting × 130-nm albumin-bound paclitaxel × Clear all
NCT04894643 2026-03-20

PARC

EBG MedAustron GmbH

Phase NA Recruiting
10 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT06853678 2025-03-03

Second-line Immunotherapy for ES-SCLC

Tianjin Medical University Cancer Institute and Hospital

Phase NA Recruiting
30 enrolled
Thoracic

Extensive Stage Small Cell Lung Cancer (ES-SCLC)

NCT04047953 2023-04-05

Paclitaxel (Albumin-bound) Combined With Oxaliplatin and S-1 Conversion Therapy for Gastric Adenocarcinoma

Peking University Cancer Hospital & Institute

Phase NA Recruiting
95 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡